ClinVar Miner

Submissions for variant NM_015102.5(NPHP4):c.3911A>G (p.His1304Arg)

gnomAD frequency: 0.00124  dbSNP: rs115488133
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000176884 SCV000228642 likely benign not specified 2016-07-26 criteria provided, single submitter clinical testing
Invitae RCV000864161 SCV001004925 benign Nephronophthisis 2024-01-19 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001099939 SCV001256432 uncertain significance Nephronophthisis 4 2017-09-08 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Illumina Laboratory Services, Illumina RCV001101945 SCV001258589 uncertain significance Senior-Loken syndrome 4 2017-09-08 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
GeneDx RCV001753581 SCV001986060 uncertain significance not provided 2020-07-02 criteria provided, single submitter clinical testing Reported previously in trans with 2 other missense variants in NPHP4 in a patient with with a complex phenotype including skeletal and renal dysplasia, immunodeficiency, retinal degeneration and ovarian failure; however this proband was also noted have multiple other nonsynonomous gene variants either in the homozygous or compound heterozygous state and to have UPD2 (Carmichael et al., 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23167750)
Mayo Clinic Laboratories, Mayo Clinic RCV001753581 SCV004227720 uncertain significance not provided 2022-10-05 criteria provided, single submitter clinical testing BS1
PreventionGenetics, part of Exact Sciences RCV003927634 SCV004741179 likely benign NPHP4-related condition 2019-09-17 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.